Filing Details

Accession Number:
0001179110-11-014203
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-10-12 17:06:53
Reporting Period:
2011-10-10
Filing Date:
2011-10-12
Accepted Time:
2011-10-12 17:06:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
882095 Gilead Sciences Inc GILD Biological Products, (No Disgnostic Substances) (2836) 943047598
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190578 C John Martin Gilead Sciences, Inc.
333 Lakeside Drive
Foster City CA 94404
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-10-10 92,320 $8.22 2,041,535 No 4 M Direct
Common Stock Disposition 2011-10-10 92,320 $40.00 1,949,215 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock option (right to buy) Disposition 2011-10-10 92,320 $0.00 92,320 $8.22
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
184,640 2012-01-29 No 4 M Direct
Footnotes
  1. Sale prices reported for the transaction reported here range from $40.00 to $40.05. Full information regarding the number of shares purchased or sold at each price will be provided to the SEC, the issuer or its shareowners upon request.
  2. The options had a 5-year vesting schedule. 20% of the options vested on January 30, 2003, the first anniversary of the date of the grant. The balance vested 5% every three months thereafter until fully vested on January 30, 2007. The options expire on January 29, 2012.